GlaxoSmithKline's Vaccine Provides 'Modest Protection' against Malaria - Pharmaceutical Processing

GlaxoSmithKline's Vaccine Provides 'Modest Protection' against Malaria Pharmaceutical Processing Study results published Friday in the NEJM showed that GlaxoSmithKline's experimental vaccine RTS,S/AS01 provided "modest protection" against malaria in infants aged six to 12 weeks, reducing episodes of the disease by around one third compared to ... and more »

Read Full Story